You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

panel reactive antibodies

Showing 1 - 25 of 8,846
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allergen-reactive Antibodies in Blood of Pollen Allergic

Enrolling by invitation
  • Pollen Allergy
  • blood withdrawal
  • Zürich, Switzerland
    Immunologie Zentrum Zürich
Apr 6, 2022

Ustekinumab in Active Crohn's Disease

Completed
  • Crohn Disease
  • Evaluation of biological predictive factors of clinical response to ustekinumab
  • Pierre-Bénite, France
    Centre hospitalier Lyon Sud
Aug 23, 2022

Panel Reactive Antibodies Trial (synthetic PreImplantation Factor)

Withdrawn
  • Panel Reactive Antibodies
  • synthetic PreImplantation Factor
  • (no location specified)
Dec 31, 2018

Gonorrhea Trial in Kilifi (4CMenB (Bexsero®) vaccine)

Completed
  • Gonorrhea
  • 4CMenB (Bexsero®) vaccine
  • Kilifi, Kenya
    KEMRI-Wellcome Trust Research Programme
Apr 13, 2022

Adult Patients Treated in Study R5459-RT-1944 Who Receive A

Not yet recruiting
  • Chronic Kidney Disease (CKD)
  • Noninterventional
  • (no location specified)
Nov 21, 2022

End Stage Renal Disease Trial in Los Angeles (Tacrolimus Extended-Release Oral Capsule)

Completed
Has Results
  • End Stage Renal Disease
  • Tacrolimus Extended-Release Oral Capsule
  • Los Angeles, California
    Cedars Sinai Medical Center
Jan 7, 2022

Haemochromatosis Trial in France (other, biological, procedure)

Recruiting
  • Haemochromatosis
  • Clinical examination
  • +14 more
  • Bobigny, France
  • +10 more
Jul 13, 2021

Platelet Refractoriness, Hematologic Malignancy Trial in Charlottesville (isatuximab 10 mg/kg)

Recruiting
  • Platelet Refractoriness
  • Hematologic Malignancy
  • isatuximab 10 mg/kg
  • Charlottesville, Virginia
    University of Virginia
Jan 27, 2023

Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)

Not yet recruiting
  • Renal Transplant Rejection
  • Induction Therapy
  • (no location specified)
Sep 22, 2022

Prognosis of Emergency Department Suspected

Completed
  • Respiratory Tract Infections
  • +4 more
  • HostDx Sepsis
  • Atlanta, Georgia
  • +6 more
Dec 2, 2021

Chronic Kidney Disease (CKD) Trial in New Haven, New York, Philadelphia (REGN5459, REGN5458)

Not yet recruiting
  • Chronic Kidney Disease (CKD)
  • New York, New York
    New York University Langone Health - Transplant Institute
Jul 11, 2022

Non-radiographic Axial Spondyloarthritis Trial (Secukinumab, Placebo)

Not yet recruiting
  • Non-radiographic Axial Spondyloarthritis
  • (no location specified)
Nov 16, 2022

Highly Sensitized Prospective Kidney Transplant Recipients Trial in San Francisco (daratumumab, belatacept, Bone marrow

Recruiting
  • Highly Sensitized Prospective Kidney Transplant Recipients
  • daratumumab
  • +2 more
  • San Francisco, California
    University of California at San Francisco Medical Center
Jan 27, 2022

Donor Specific B Cells and Antibody Mediated Rejection

Terminated
  • Sensitized Kidney Transplant Recipients
    • Madison, Wisconsin
      University of Wisconsin Hospital and Clinics
    Dec 13, 2021

    Antibody-mediated Rejection, Cardiac Transplant Trial in Rochester (Daratumumab and hyaluronidase-fihj)

    Enrolling by invitation
    • Antibody-mediated Rejection
    • Cardiac Transplant
    • Daratumumab and hyaluronidase-fihj
    • Rochester, Minnesota
      Mayo Clinic Rochester
    Apr 11, 2022

    Cell-Free Nucleic Acids Trial (Cell free DNA analysis)

    Not yet recruiting
    • Cell-Free Nucleic Acids
    • Cell free DNA analysis
    • (no location specified)
    Jan 27, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

    Not yet recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +12 more
    • Biopsy
    • +8 more
    • (no location specified)
    Jun 8, 2023

    Biomarker Panel in Ovarian Torsion

    Recruiting
    • Ovary Torsion
    • Adnexal Torsion
    • biomakers for ovarian torsion
    • peritoneal fluid proteins analysis
    • Ashdod, Israel
    • +1 more
    Sep 17, 2021

    Highly Sensitized Prospective Kidney Transplant Recipients Trial in Durham (carfilzomib, belatacept, Bone marrow aspiration)

    Recruiting
    • Highly Sensitized Prospective Kidney Transplant Recipients
    • carfilzomib
    • +2 more
    • Durham, North Carolina
      Duke Transplant Center, Duke University Medical Center
    Jan 11, 2022

    Kidney Transplantation, End Stage Kidney Disease (ESRD) Trial in Chicago (Belatacept Injection)

    Recruiting
    • Kidney Transplantation
    • End Stage Kidney Disease (ESRD)
    • Belatacept Injection
    • Chicago, Illinois
      University of Chicago
    May 13, 2022

    HIV-1-infection Trial in United States (426c.Mod.Core-C4b 30 mcg, 426c.Mod.Core-C4b 100 mcg, 426c.Mod.Core-C4b 300 mcg)

    Recruiting
    • HIV-1-infection
    • 426c.Mod.Core-C4b 30 mcg
    • +3 more
    • Birmingham, Alabama
    • +5 more
    Jul 25, 2022

    Antibody-mediated Rejection, Hyperacute Rejection of Cardiac Transplant, Left Ventricular Dysfunction Trial in Los Angeles

    Completed
    Has Results
    • Antibody-mediated Rejection
    • +4 more
    • Los Angeles, California
      Cedars Sinai Medical Center, Heart Institute
    Apr 30, 2021

    Immune System Disorder Trial in Spain, United States (Isatuximab SAR650984, Acetaminophen (paracetamol) or equivalent,

    Completed
    • Immune System Disorder
    • Isatuximab SAR650984
    • +5 more
    • San Francisco, California
    • +5 more
    May 6, 2022

    Pilot Study of Gut Commensals in Antiphospholipid Syndrome

    Active, not recruiting
    • Antiphospholipid Syndrome (APS)
      • New Haven, Connecticut
        Yale University School of Medicine; Yale-New Haven Hospital
      Apr 25, 2022

      BD OneFlow CLPD Panel on BD FACSLyric System.

      Recruiting
      • Chronic Lymphoproliferative Diseases (CLPD)
      • BD OneFlow LST, and B-CLPD T1 to T4 Assays
      • Chapel Hill, North Carolina
      • +4 more
      Jan 19, 2023